Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 29, 2023
Undifferentiated and Dedifferentiated Metastatic Melanomas Masquerading as Soft Tissue Sarcomas: Mutational Signature Analysis and Immunotherapy ResponseIsrael S Kasago, Walid K Chatila, Cecilia M Lezcano, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2022
POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLCMarina K Baine, Christopher A Febres-Aldana, Jason C Chang, et al.
Nature|November 7, 2024
Cellular ATP demand creates metabolically distinct subpopulations of mitochondriaKeun Woo Ryu, Tak Shun Fung, Daphne C Baker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2022
Rb Tumor Suppressor in Small Cell Lung Cancer: Combined Genomic and IHC Analysis with a Description of a Distinct Rb-Proficient SubsetChristopher A Febres-Aldana, Jason C Chang, Ryan Ptashkin, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
RRAS and RRAS2 mutations are recurrent oncogenic drivers in lung cancer and are sensitive to the pan-RAS inhibitor RMC-6236Alexander J Pfeil, Tom Zhang, Ryan Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2026
RRAS and RRAS2 mutations are recurrent oncogenic drivers in lung cancer and are sensitive to the pan-RAS inhibitor RMC-6236Alexander J Pfeil, Tom Zhang, Ryan Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2024
HER2 Antibody-Drug Conjugates Are Active against Desmoplastic Small Round Cell TumorTom Zhang, Christopher A Febres-Aldana, Zebing Liu, et al.
Oncogene|May 31, 2025
Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an ILK-SFK-YAP signaling axis in lung adenocarcinomaRocky Shi, Dylan A Farnsworth, Christopher A Febres-Aldana, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 7, 2024
Comparison of Immunohistochemistry, Next-generation Sequencing and Fluorescence In Situ Hybridization for Detection of MTAP Loss in Pleural MesotheliomaChristopher A Febres-Aldana, Jason C Chang, Achim A Jungbluth, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 29, 2024
Analysis of ASCL1/NEUROD1/POU2F3/YAP1 Yields Novel Insights for the Diagnosis of Olfactory Neuroblastoma and Identifies Sinonasal Tuft Cell-Like CarcinomaChristopher A Febres-Aldana, Mahmoud M Elsayad, Maelle Saliba, et al.
Pageof 5